Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

© 2017, National Academy of Sciences. All rights reserved. Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we devel...

Full description

Bibliographic Details
Main Authors: Ludwig, B., Ludwig, S., Steffen, A., Knauf, Y., Zimerman, B., Heinke, S., Lehmann, S., Schubert, U., Schmid, J., Bleyer, M., Schönmann, U., Colton, C., Bonifacio, E., Solimena, Michele, Reichel, A., Schally, A., Rotem, A., Barkai, U., Grinberg-Rashi, H., Kaup, F., Avni, Y., Jones, P., Bornstein, S.
Format: Journal Article
Published: National Academy of Sciences 2017
Online Access:http://hdl.handle.net/20.500.11937/73057
_version_ 1848762912333627392
author Ludwig, B.
Ludwig, S.
Steffen, A.
Knauf, Y.
Zimerman, B.
Heinke, S.
Lehmann, S.
Schubert, U.
Schmid, J.
Bleyer, M.
Schönmann, U.
Colton, C.
Bonifacio, E.
Solimena, Michele
Reichel, A.
Schally, A.
Rotem, A.
Barkai, U.
Grinberg-Rashi, H.
Kaup, F.
Avni, Y.
Jones, P.
Bornstein, S.
author_facet Ludwig, B.
Ludwig, S.
Steffen, A.
Knauf, Y.
Zimerman, B.
Heinke, S.
Lehmann, S.
Schubert, U.
Schmid, J.
Bleyer, M.
Schönmann, U.
Colton, C.
Bonifacio, E.
Solimena, Michele
Reichel, A.
Schally, A.
Rotem, A.
Barkai, U.
Grinberg-Rashi, H.
Kaup, F.
Avni, Y.
Jones, P.
Bornstein, S.
author_sort Ludwig, B.
building Curtin Institutional Repository
collection Online Access
description © 2017, National Academy of Sciences. All rights reserved. Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions.
first_indexed 2025-11-14T10:55:06Z
format Journal Article
id curtin-20.500.11937-73057
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:55:06Z
publishDate 2017
publisher National Academy of Sciences
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-730572018-12-13T09:35:22Z Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes Ludwig, B. Ludwig, S. Steffen, A. Knauf, Y. Zimerman, B. Heinke, S. Lehmann, S. Schubert, U. Schmid, J. Bleyer, M. Schönmann, U. Colton, C. Bonifacio, E. Solimena, Michele Reichel, A. Schally, A. Rotem, A. Barkai, U. Grinberg-Rashi, H. Kaup, F. Avni, Y. Jones, P. Bornstein, S. © 2017, National Academy of Sciences. All rights reserved. Transplantation of pancreatic islets for treating type 1 diabetes is restricted to patients with critical metabolic lability resulting from the need for immunosuppression and the shortage of donor organs. To overcome these barriers, we developed a strategy to macroencap-sulate islets from different sources that allow their survival and function without immunosuppression. Here we report successful and safe transplantation of porcine islets with a bioartificial pancreas device in diabetic primates without any immune suppression. This strategy should lead to pioneering clinical trials with xenotransplantation for treatment of diabetes and, thereby, represents a previously unidentified approach to efficient cell replacement for a broad spectrum of endocrine disorders and other organ dysfunctions. 2017 Journal Article http://hdl.handle.net/20.500.11937/73057 10.1073/pnas.1708420114 National Academy of Sciences restricted
spellingShingle Ludwig, B.
Ludwig, S.
Steffen, A.
Knauf, Y.
Zimerman, B.
Heinke, S.
Lehmann, S.
Schubert, U.
Schmid, J.
Bleyer, M.
Schönmann, U.
Colton, C.
Bonifacio, E.
Solimena, Michele
Reichel, A.
Schally, A.
Rotem, A.
Barkai, U.
Grinberg-Rashi, H.
Kaup, F.
Avni, Y.
Jones, P.
Bornstein, S.
Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title_full Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title_fullStr Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title_full_unstemmed Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title_short Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
title_sort favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
url http://hdl.handle.net/20.500.11937/73057